Evidence map›Paper›PMID 34039407›Full record

ArticleBiology direct2021

Common pathways and functional profiles reveal underlying patterns in Breast, Kidney and Lung cancers.

Sergio Romera-Giner, Zoraida Andreu Martínez, Francisco García-García, Marta R Hidalgo

Open access · goldAbstract read
In one paragraph

Article in Biology direct, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. No Time to Die: How Kidney Cancer Evades Cell Death.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Sergio Romera-GinerBioinformatics & Biostatistics Unit, Principe Felipe Research Center, 46012, Valencia, Spain.
Zoraida Andreu MartínezBioinformatics & Biostatistics Unit, Principe Felipe Research Center, 46012, Valencia, Spain.
Francisco García-GarcíaBioinformatics & Biostatistics Unit, Principe Felipe Research Center, 46012, Valencia, Spain.
Marta R HidalgoBioinformatics & Biostatistics Unit, Principe Felipe Research Center, 46012, Valencia, Spain. mhidalgo@cipf.es.ORCID 0000-0002-5801-7804
Atos (Spain) · ESCentro de Investigacion Principe Felipe · ESElixir Medical (United States) · USFundación Instituto Valenciano de Oncología · ES

Funding

Instituto de Salud Carlos III PT17/0009/0015
6 · The paper itself

Abstract

backgroundCancer is a major health problem which presents a high heterogeneity. In this work we explore omics data from Breast, Kidney and Lung cancers at different levels as signalling pathways, functions and miRNAs, as part of the CAMDA 2019 Hi-Res Cancer Data Integration Challenge. Our goal is to find common functional patterns which give rise to the generic microenvironment in these cancers and contribute to a better understanding of cancer pathogenesis and a possible clinical translation down further studies.

resultsAfter a tumor versus normal tissue comparison of the signaling pathways and cell functions, we found 828 subpathways, 912 Gene Ontology terms and 91 Uniprot keywords commonly significant to the three studied tumors. Such features interestingly show the power to classify tumor samples into subgroups with different survival times, and predict tumor state and tissue of origin through machine learning techniques. We also found cancer-specific alternative activation subpathways, such as the ones activating STAT5A in ErbB signaling pathway. miRNAs evaluation show the role of miRNAs, such as mir-184 and mir-206, as regulators of many cancer pathways and their value in prognoses.

conclusionsThe study of the common functional and pathway activities of different cancers is an interesting approach to understand molecular mechanisms of the tumoral process regardless of their tissue of origin. The existence of platforms as the CAMDA challenges provide the opportunity to share knowledge and improve future scientific research and clinical practice.

Indexed as

Gene Expression Regulation, NeoplasticSignal TransductionTranscriptomeBreast NeoplasmsGene Expression ProfilingHumansKidney NeoplasmsLung NeoplasmsMicroRNAsMicroRNAsArtificial intelligenceCancerFunctional analysismiRNAsPathwaysSignalingSurvival

Identifiers

PMID34039407
PMCPMC8152308
OpenAlexW3159306245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.